The Research and Development team at ANGLE is dedicated to advancing the Parsortix® technology by conducting cutting-edge clinical studies and validating product efficacy. They collaborate closely with medical professionals to ensure the capture and analysis of viable circulating tumor cells is effective, while also focusing on innovative microfluidics design to enhance product performance. Their efforts drive the development of new applications and reinforce ANGLE's leadership in liquid biopsy solutions.